According to the TCGA report, most endometrioid tumors expressed frequent mutations in PTEN, CTNNB1, PIK3CA, ARID1A, and KRAS. By contrast, serous tumors and high-grade endometrioid tumors had frequent P53 mutations. Here, TP53 is linked to endometrioid tumor.